- Home
- KRYS vs GGAL Comparison
KRYS vs GGAL Comparison
Compare KRYS & GGAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- GGAL
- Stock Information
- Founded
- KRYS 2015
- GGAL 1905
- Country
- KRYS United States
- GGAL Argentina
- Employees
- KRYS N/A
- GGAL 12440
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- GGAL Commercial Banks
- Sector
- KRYS Health Care
- GGAL Finance
- Exchange
- KRYS Nasdaq
- GGAL Nasdaq
- Market Cap
- KRYS 4.3B
- GGAL 5.2B
- IPO Year
- KRYS 2017
- GGAL N/A
- Fundamental
- Price
- KRYS $144.86
- GGAL $31.45
- Analyst Decision
- KRYS Strong Buy
- GGAL Buy
- Analyst Count
- KRYS 10
- GGAL 2
- Target Price
- KRYS $204.90
- GGAL $92.00
- AVG Volume (30 Days)
- KRYS 268.2K
- GGAL 3.0M
- Earning Date
- KRYS 11-03-2025
- GGAL 01-01-0001
- Dividend Yield
- KRYS N/A
- GGAL 1.81%
- EPS Growth
- KRYS 36.22
- GGAL N/A
- EPS
- KRYS 4.91
- GGAL 0.60
- Revenue
- KRYS $359,205,000.00
- GGAL $4,565,013,669.00
- Revenue This Year
- KRYS $34.33
- GGAL $11.82
- Revenue Next Year
- KRYS $47.84
- GGAL $24.80
- P/E Ratio
- KRYS $29.46
- GGAL $5.63
- Revenue Growth
- KRYS 116.08
- GGAL N/A
- 52 Week Low
- KRYS $122.80
- GGAL $29.23
- 52 Week High
- KRYS $207.84
- GGAL $74.00
- Technical
- Relative Strength Index (RSI)
- KRYS 48.61
- GGAL 25.02
- Support Level
- KRYS $136.73
- GGAL $29.23
- Resistance Level
- KRYS $152.96
- GGAL $32.80
- Average True Range (ATR)
- KRYS 4.68
- GGAL 2.15
- MACD
- KRYS -0.69
- GGAL -0.86
- Stochastic Oscillator
- KRYS 50.09
- GGAL 14.08
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About GGAL Grupo Financiero Galicia S.A.
Grupo Financiero Galicia SA is a financial service holding company. It provides general banking services, proprietary brand credit card services, personal loans, insurance, and other services. The company's operating business segments are Banks, Ecosistema Naranja X, Insurance, Adjustments, and Other Businesses. It generates maximum revenue from Banks. Geographically its operate in Argentina, Uruguay, and the majority of its revenue comes from Argentina.